Bochao Jia

597 total citations · 2 hit papers
33 papers, 358 citations indexed

About

Bochao Jia is a scholar working on Rheumatology, Epidemiology and Genetics. According to data from OpenAlex, Bochao Jia has authored 33 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 6 papers in Epidemiology and 6 papers in Genetics. Recurrent topics in Bochao Jia's work include Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Bochao Jia is often cited by papers focused on Systemic Lupus Erythematosus Research (8 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Bochao Jia collaborates with scholars based in United States, China and United Kingdom. Bochao Jia's co-authors include Faming Liang, Thomas Dörner, Maria Silk, Eric F. Morand, Christina Dickson, Michelle Petri, Marta Mosca, Daniel J. Wallace, Ronald van Vollenhoven and Yoshiya Tanaka and has published in prestigious journals such as The Lancet, Journal of the American Statistical Association and Biometrics.

In The Last Decade

Bochao Jia

28 papers receiving 356 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)

2023 89 citations Michelle Petri, Ian N Bruce et al. The Lancet profile →
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)

2023 79 citations Eric F. Morand, Edward M Vital et al. The Lancet profile →

Peers

Countries citing papers authored by Bochao Jia

Since Specialization

Citations

This map shows the geographic impact of Bochao Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bochao Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bochao Jia more than expected).

Fields of papers citing papers by Bochao Jia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bochao Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bochao Jia. The network helps show where Bochao Jia may publish in the future.

Co-authorship network of co-authors of Bochao Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Bochao Jia. A scholar is included among the top collaborators of Bochao Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bochao Jia. Bochao Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potential Key Genes for Giant Cell Arteritis Revealed Based on Single-Cell Sequencing and Mendelian Randomization Analysis 2025 ·International Archives of Allergy and Immunology ·Tao Cheng, Joseph Chen, (unknown), Bochao Jia, (unknown), Yunkai Wang, Wei Yi, (unknown)	1
2	Global and regional burden of four drug use disorders in the elderly, 1990 to 2021: an analysis of the global burden of disease study 2025 ·BMC Geriatrics ·Bochao Jia, (unknown), Zhiqi Li, (unknown), Mengxue Wang, Chongjun Zhao, Yi Wei, Zhenquan Liu, (unknown)	0
3	Application of monoclonal antibodies in diabetes: A bibliometric analysis from 2004–2024 2025 ·Human Vaccines & Immunotherapeutics ·(unknown), Bochao Jia, (unknown), Xuexue Zhang, Miaoran Wang, Ning Sun, Rui Zhang, Qiuyan Li	0
4	Artificial intelligence and atrial fibrillation: A bibliometric analysis from 2013 to 2023 2024 ·Heliyon ·Bochao Jia, Jiafan Chen, (unknown), Huan Wang, Yi Wei, (unknown)	4
5	Research trends and key contributors in studies on influenza vaccines for children: A 20-year bibliometric analysis 2024 ·Human Vaccines & Immunotherapeutics ·Ning Sun, Rui-Li Wei, Bochao Jia, (unknown), Zirong Li, Xiaowei Nie, (unknown), Miaoran Wang, Qiuyan Li	0
6	Causal association between blood metabolites and risk of hypertension: a Mendelian randomization study 2024 ·Frontiers in Cardiovascular Medicine ·Tao Cheng, (unknown), (unknown), Huan Wang, Wenjing Xue, Xuesong Zhang, Bochao Jia, (unknown)	3
7	Lateral retraction could achieve better early postoperative knee function than patellar eversion in total knee arthroplasty: a systematic review and meta-analysis. 2023 ·PubMed ·(unknown), Bochao Jia, (unknown), (unknown), Yizhen Wang, (unknown), (unknown)	0
8	Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II) breakdown → 2023 ·The Lancet ·Michelle Petri, Ian N Bruce, Thomas Dörner, Yoshiya Tanaka, Eric F. Morand, Kenneth Kalunian, Mario H. Cardiel, Maria Silk, Christina Dickson, (unknown), Lu Zhang, Bochao Jia, (unknown), (unknown), Marta Mosca	89
9	Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I) breakdown → 2023 ·The Lancet ·Eric F. Morand, Edward M Vital, Michelle Petri, Ronald van Vollenhoven, Daniel J. Wallace, Marta Mosca, Richard Furie, Maria Silk, Christina Dickson, (unknown), Bochao Jia, Brenda Crowe, Inmaculada de la Torre, Thomas Dörner	79
10	Mirikizumab Regulates Genes Involved in Ulcerative Colitis Disease Activity and Anti-TNF Resistance: Results From a Phase 2 Study 2023 ·Clinical and Translational Gastroenterology ·(unknown), Jochen Schmitz, Nick Powell, Richard E. Higgs, Klaus Gottlieb, Yushi Liu, Bochao Jia, Jay Tuttle, William J. Sandborn, Bruce E. Sands, Geert D’Haens, Walter Reinisch, Venkatesh Krishnan	15
11	Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial 2022 ·Arthritis Research & Therapy ·Thomas Dörner, Ronald van Vollenhoven, Andrea Doria, Bochao Jia, Jorge Alfonso Ross Terres, Maria Silk, Stephanie de Bono, Peter Fischer, Daniel J. Wallace	32
12	Maintenance of Patient-Reported Outcomes in Baricitinib-Treated Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Post Hoc Analyses from Two Phase 3 Trials 2022 ·Rheumatology and Therapy ·(unknown), Jianmin Wu, Bochao Jia, Hong Zhang, (unknown), Julie Birt, (unknown), Huaxiang Liu, Clifton O. Bingham	3
13	POS0190 EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM TWO RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDIES 2022 ·Annals of the Rheumatic Diseases ·Eric F. Morand, (unknown), R. Furie, Edward M Vital, (unknown), Kenneth Kalunian, Marta Mosca, Thomas Dörner, Daniel J. Wallace, (unknown), (unknown), Inmaculada de la Torre, (unknown), Bochao Jia, Byron Crowe, M. A. Petri	6
14	Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study 2021 ·Rheumatology and Therapy ·Alvin F. Wells, Bochao Jia, Li Xie, Guillermo J. Valenzuela, Edward Keystone, Zhanguo Li, Amanda Quebe, (unknown), (unknown), Boulos Haraoui	3
15	DOP65 Mirikizumab regulates genes involved in anti-TNF resistance and ulcerative colitis disease activity 2020 ·Journal of Crohn s and Colitis ·(unknown), Jochen Schmitz, Nick Powell, (unknown), Klaus Gottlieb, (unknown), Bochao Jia, Jay Tuttle, William J. Sandborn, B E Sands, Venkatesh Krishnan	3
16	Markov Neighborhood Regression for High-Dimensional Inference 2020 ·Journal of the American Statistical Association ·Faming Liang, (unknown), Bochao Jia	7
17	Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study 2020 ·Lara D. Veeken ·Josef S Smolen, Li Xie, Bochao Jia, Peter C. Taylor, Gerd R Burmester, Yoshiya Tanaka, (unknown), Anabela Cardoso, (unknown), Chad D. Walls, Maxime Dougados	17
18	Joint Bayesian-Incorporating Estimation of Multiple Gaussian Graphical Models to Study Brain Connectivity Development in Adolescence 2019 ·IEEE Transactions on Medical Imaging ·Aiying Zhang, Biao Cai, Wenxing Hu, Bochao Jia, Faming Liang, Tony W. Wilson, Julia M. Stephen, Vince D. Calhoun, Yu‐Ping Wang	9
19	Fast hybrid Bayesian integrative learning of multiple gene regulatory networks for type 1 diabetes 2019 ·Biostatistics ·Bochao Jia, Faming Liang, (unknown)	2
20	Learning Multiple Gene Regulatory Networks in Type 1 Diabetes through a Fast Bayesian Integrative Method 2018 ·Bochao Jia, Faming Liang	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact